GABA Labs Responds to Surgeon General’s Advisory on Alcohol and Cancer

The recent advisory from the U.S. Surgeon General highlights a critical public health issue: alcohol consumption as a leading preventable cause of cancer. With nearly 100,000 cancer cases and 20,000 deaths annually in the U.S., it is crucial to close the consumer knowledge gap and offer healthier alternatives.

Only 45% of Americans recognize alcohol’s link to cancer, a figure unchanged for decades. In the era of the wellness movement and increasing interest in health-conscious choices, this knowledge gap underscores the need for more comprehensive educational campaigns and better access to alternatives.

GABA Labs’ Chief Scientific Officer, Professor David Nutt, states, “It’s time to challenge alcohol sector’s influence over how alcohol is discussed publicly, as well as the industry’s influence on public policy. Consumers deserve information transparency and real drinking alternatives to push back against harmful norms. Over my career, I’ve seen the alcohol industry cloud the issue. Change won’t come from within.”

Many companies are working to address this issue by offering effective, science-backed alternatives to alcohol, empowering consumers to make healthier choices without sacrificing sociability. Botanical technology, as demonstrated by products like GABA Labs' SENTIA Spirits line, is ready to revolutionize social drinking today.

“The evidence is clear: alcohol is a major carcinogen, and even moderate drinking poses significant risks,” adds Professor Nutt. “GABA Spirits, a new category of functional drinks, use neuroscience to provide relaxation and connection without alcohol’s toxicity. SENTIA Spirits, brings this revolutionary concept to life. Alcohol is ancient technology—GABA Spirits signal a safer, liberating future.”

GABA Labs advocates for collaboration with policymakers, health organizations, and industry leaders to ensure functional alcohol alternatives gain visibility. “By enabling better consumer choices in social settings, we can reduce alcohol-related harms and contribute positively to the global economy,” says David Orren, CEO of GABA Labs.

The low and no-alcohol sector is growing exponentially. SENTIA Spirits is now reaching consumers globally with over 100,000 customers signed up to receive product and more information on GABA active alternatives. Exports to the USA make up more than half of sales. By collaborating with research institutions and developing products like the Alcarelle synthetic alcohol series, GABA Labs is positioned to redefine adult social drinking.

GABA Labs aims to deliver Alcarelle as an ingredient for the alcohol industry to create the next-generation functional beverages. But the revolution is here now. Founded by Professor David Nutt and David Orren, and backed by cutting-edge research, SENTIA’s plant-based GABA Spirits offer a scientifically supported, non-alcoholic alternative to traditional drinking.

For more information on Alcarelle and investment information, visit www.gabalabs.com. For press enquiries, contact press@sentiaspirits.com.